Literature DB >> 21155929

The 'dark' side of sedation: 12 years of office-based pediatric deep sedation for electroretinography in the dark.

Kirk Lalwani1, Brian D Tompkins, Kevin Burnes, Melissa R Krahmer, Mark E Pennesi, Richard G Weleber.   

Abstract

OBJECTIVES: Analyze pediatric ERG data for adverse events, interventions, and outcomes of propofol sedations performed in near-complete darkness. AIM: To demonstrate that deep sedation with propofol for ERG can be performed efficiently and safely in children in near-total darkness.
BACKGROUND: Full-field electroretinography (ERG) is a valuable tool for the diagnosis of vision loss in children. The ERG measures the electrical activity of the retina. In children, ERG quality significantly improves with deep sedation by allowing easier eye electrode placement and decreasing motion artifacts. As this procedure must be performed in darkness, administering sedation imposes unique challenges. METHODS AND MATERIALS: ERGs are performed outside of the operating room in our hospital's electrophysiology suite. IVs are placed, and patients are allowed to adapt to complete darkness. An anesthesiologist then administers propofol sedation in the dark with the aid of a red-filter light source and monitor light shields. Data were collected on 379 patients (411 ERGs) performed from 1996 to 2008. These records were reviewed and analyzed for demographic, medical, and anesthetic data.
RESULTS: Propofol sedation resulted in an ERG completion rate of 99.5%. During sedation, 8.5% (35) of patients experienced minor respiratory complications such as airway obstruction that resulted in an oxygen saturation <90%. A total of 9.7% (40) of patients required minor airway interventions such as a chin lift.
CONCLUSIONS: We demonstrated that pediatric sedation is a safe, efficient, and a cost-effective method for measuring ERGs in a challenging environment. The incidence of minor complications is low and appears similar to other studies of propofol sedation.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21155929     DOI: 10.1111/j.1460-9592.2010.03462.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  3 in total

1.  Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.

Authors:  Paul Yang; Keith V Michaels; Robert J Courtney; Yuquan Wen; Daniel A Greninger; Leah Reznick; Daniel J Karr; Lorri B Wilson; Richard G Weleber; Mark E Pennesi
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

2.  Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1.

Authors:  Mark E Pennesi; Niamh B Stover; Edwin M Stone; Pei-Wen Chiang; Richard G Weleber
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

3.  Ophthalmic findings in an infant with phosphomannomutase deficiency.

Authors:  Wyatt B Messenger; Paul Yang; Mark E Pennesi
Journal:  Doc Ophthalmol       Date:  2014-02-04       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.